Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |